Cystic Fibrosis: all 1,605 studies
Page 1 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.
- Type 2 Inflammation in Adults With Cystic FibrosisNot yet recruitingNCT07892443
- Management of Breast Fibroadenoma: Comparing Observation, Microwave Ablation, and Surgical ExcisionNot yet recruitingNCT07890766Not applicable
- A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related DisordersRecruitingNCT07889973
- PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in TreatmentRecruitingNCT07885410
- SPutum Induction and Nebuliser deviCEs for Patients With CFNot yet recruitingNCT07879651Not applicable
- Reproducibility of Continuous Glucose Monitoring (CGM) in the Assessment of Glucose Metabolism Disorders in Children With Cystic FibrosisNot yet recruitingNCT07851831Not applicable
- A Phase 1 Relative Bioavailability Study of a VX-581 Tablet FormulationRecruitingNCT07813039Phase 1
- Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic FibrosisRecruitingNCT07809867Phase 4
- MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)Not yet recruitingNCT07780344Not applicable
- Autogenic Drainage Versus Mechanical Percussion in Children With Cystic FibrosisRecruitingNCT07729787Not applicable
- HFCWO in Children With Non-CF BronchiectasisNot yet recruitingNCT07722364Not applicable
- Rethinking Early Airway Clearence TherapiesNot yet recruitingNCT07696338Not applicable
- Heart and Blood Vessels Health in People With Cystic FibrosisNot yet recruitingNCT07692594
- Verapamil Effect in Cystic Fibrosis-related DysglycemiaNot yet recruitingNCT07688070Phase 2
- Home Air Pollution in Children With Cystic Fibrosis StudyNot yet recruitingNCT07665203
- Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)RecruitingNCT07629986
- Reference Equations and Normative Data for Isometric Quadriceps and Handgrip Muscles STrength in Southern European Populations - RESTart: a Multicentre StudyNot yet recruitingNCT07628530
- Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic FibrosisRecruitingNCT07569419Early Phase 1
- A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.RecruitingNCT07559175Phase 2
- Effects of High-Frequency Chest Wall Oscillation Combined With Concurrent Training on Cough,in Cystic Fibrosis PatientsNot yet recruitingNCT07519460Not applicable
- Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic FibrosisRecruitingNCT07508904Not applicable
- ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono HealthRecruitingNCT07505797
- Tele-Rehabilitation in Adults With Cystic FibrosisNot yet recruitingNCT07500493Not applicable
- Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 YearsRecruitingNCT07485543Early Phase 1
- Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic FibrosisRecruitingNCT07484607
- MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure .Not yet recruitingNCT07454681
- Phase 2 Study to Assess the Safety and Efficacy of ANG003RecruitingNCT07450547Phase 2
- Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference CenterEnrolling by invitationNCT07442682
- Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsRecruitingNCT07437105Phase 1
- ACT With CF Self-Help ToolkitRecruitingNCT07436351Not applicable
- GRAnulomatous MAstitis REGistry StudyRecruitingNCT07422870
- Clean Air for Rare MUcociliary Clearance dIsordersEnrolling by invitationNCT07417267Not applicable
- Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR FunctionNot yet recruitingNCT07414810Not applicable
- A Prospective Study of Advanced Diagnostics in People With an Unclear Diagnosis of Cystic FibrosisNot yet recruitingNCT07402434
- Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis HouseholdsRecruitingNCT07369414
- Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.RecruitingNCT07363304
- Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic FibrosisRecruitingNCT07342920
- Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorRecruitingNCT07314229Not applicable
- Study to Enable New Diagnostics for Pulmonary Microbes in People With CFRecruitingNCT07312734
- Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric PopulationRecruitingNCT07303621
- Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and BronchiectasisRecruitingNCT07289100
- Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.Not yet recruitingNCT07289035Phase 2
- Evaluation of VX-581 in Healthy Participants and in Participants With Cystic FibrosisRecruitingNCT07283770Phase 1
- Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung InfectionsNot yet recruitingNCT07280598Phase 1
- Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung InfectionRecruitingNCT07275905Phase 1
- A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised MedicineRecruitingNCT07274631
- The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic ProgramRecruitingNCT07255131Not applicable
- Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean DietRecruitingNCT07223255Not applicable
- MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic FibrosisRecruitingNCT07192679
- Nutrition Supplement for Cystic FibrosisNot yet recruitingNCT07163078Not applicable
- Ensuring Access to Optimal Therapy in CF: The ENACT StudyRecruitingNCT07148739Phase 4
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)RecruitingNCT07083557
- CF Wellness ProgramRecruitingNCT07071324Not applicable
- Comparative Effects of Mechanical and Manual Airway Clearance Techniques in Cystic FibrosisNot yet recruitingNCT07062939Not applicable
- TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of AgeRecruitingNCT07048574
- OnTrackCF: Engagement, Feasibility, and Acceptability StudyRecruitingNCT07031323Not applicable
- Remote Exercise to Improve Physical Activity Levels and Markers of Heart Health in Cystic Fibrosis (RHH-CF)Not yet recruitingNCT07027553Not applicable
- Study With Phage for CF Subjects With Pseudomonas Lung InfectionRecruitingNCT06998043Phase 2
- Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator TherapyRecruitingNCT06996951Phase 3
- Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung DiseaseRecruitingNCT06985225
- Physical Impairments in Children With Cystic FibrosisRecruitingNCT06984679
- Effectiveness of Gamified Mobile Health Apps for Airway Clearance Therapy in Children and Adolescents With Cystic FibrosisNot yet recruitingNCT06958094Not applicable
- Remote Sputum Collection in Cystic FibrosisRecruitingNCT06950892
- Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic FibrosisRecruitingNCT06940531
- Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis PatientsRecruitingNCT06915961
- Sweat Testing in Infants: Comparing Sweat Collection on Upper Vs Lower LimbsNot yet recruitingNCT06902363Not applicable
- Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)RecruitingNCT06837181
- Evaluation of New Device for Beta-adrenergic Sweat Test in the Context of Stratification of Patient With Cystic FibrosisRecruitingNCT06836453Not applicable
- A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their OffspringRecruitingNCT06797206
- Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic FibrosisRecruitingNCT06747858Phase 2
- Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)RecruitingNCT06683092
- Streamlined Treatment of Pulmonary Exacerbations in PediatricsRecruitingNCT06654752Not applicable
- Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic FibrosisRecruitingNCT06616857Not applicable
- Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic FibrosisRecruitingNCT06602869
- CF Organization of Care in the Era of Highly Effective Modulator.RecruitingNCT06599892
- Kidney Function in People With Cystic Fibrosis in the Era of HEMTRecruitingNCT06595420
- Feasibility of Cough Monitoring in ChildrenRecruitingNCT06587126
- Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic FibrosisRecruitingNCT06560463
- Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary ExacerbationsRecruitingNCT06546943
- FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesRecruitingNCT06539169
- Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathRecruitingNCT06528418
- A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)RecruitingNCT06526923Phase 1/2
- Acoustic Waveform Respiratory EvaluationRecruitingNCT06512064Not applicable
- Physical Activity Profile and Sedentary Behaviour in Adults With Cystic FibrosisRecruitingNCT06507956
- A Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsRecruitingNCT06504589
- Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled TrialRecruitingNCT06457451Not applicable
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisRecruitingNCT06429176Phase 2
- Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic FibrosisRecruitingNCT06413459
- Maralixibat in Patients With Cystic Fibrosis and ConstipationRecruitingNCT06413368Phase 2/3
- Circadian Rhythm Disorders in Children With Cystic Fibrosis Under CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) ModulatorsRecruitingNCT06370962
- Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI)RecruitingNCT06368388
- Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.RecruitingNCT06364176Phase 2
- Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.RecruitingNCT06356246
- A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic FibrosisRecruitingNCT06350149Not applicable
- Regional Monitoring of CF Lung DiseaseRecruitingNCT06339593Early Phase 1
- Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy TreatmentRecruitingNCT06327802
- e-Health Program to Prevent Exacerbations in the Cystic Fibrosis PopulationRecruitingNCT06313827Not applicable
- CFTR Modulators in Pregnancy and PostpartumRecruitingNCT06302270
- Assessment of Patients Not Concluded After Neonatal Screening of Cystic Fibrosis.Not yet recruitingNCT06300567
- Health Outcomes of Parents With Cystic Fibrosis-Aim 2RecruitingNCT06296394